))
Exploring the Intersection of Biotech and Corporate VC with Danjuma Quarless
Manage episode 454784532 series 3591968
Contenuto fornito da LaunchBio. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da LaunchBio o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
In this episode of the NextGen VC podcast, hosts Mike Hostetler and Jen sit down with Danjuma Quarless from AbbVie Ventures to delve into the world of corporate venture capital. Danjuma shares insights on how corporate VCs like AbbVie differ from traditional VCs, particularly in the biotech and pharmaceutical industries. Listeners will learn about the strategic focus of AbbVie Ventures, the importance of scientific and competitive differentiation in securing investment, and the fluid communication within AbbVie's ecosystem. Danjuma also shares his personal journey from a research scientist to a venture capitalist, offering valuable advice for those looking to break into the venture capital space. The podcast also touches on the current trends in biotech, the challenges and opportunities in various regional ecosystems, and the importance of promoting diversity within the venture capital industry. Tune in to hear about the latest innovations in biotech, the differences in investment approaches between various regions, and how AbbVie Ventures aims to build communities and support underrepresented groups in the industry.
10 episodi
Condividi
